The Standard in Renal Research
The organization’s scientific leaders and more than 65 national leaders collaborate with sponsors to develop new strategies for the prevention and management of kidney and metabolic disease including dialysis, chronic kidney disease, focal segmental glomerulosclerosis, diabetic kidney disease, acute kidney injury and IgA nephropathy as well as the utility of genetics in drug development and discovery.
George Clinical leverages the in-depth expertise of our scientific leadership to design effective studies, select the best sites from more than 20 internationally, and accelerate recruitment. Our scientific leaders generate strong evidence to implement real change in treatments, clinical practice and policy as shown by success managing nearly 70 kidney studies around the world.
How is the organization improving kidney clinical research?
- Sponsors are increasingly benefiting from collaborating with key opinion leaders from the earliest stages envisioning a trial to the final detailed meta-analysis and clinical conclusions.
- By aligning with a veteran partner versed in everything from protocol design to site analysis to project management and regulatory compliance, sponsors are reducing time to initiate and complete studies as well as the risk of disruption or study failure.
- To accelerate the time-to-market, George Clinical launched the Global Kidney Patients Trials Network (GKPTN link to this web page) to improve sponsors’ recruitment path while reducing overall study cost.
- By bringing patients, established sites, sponsors and trials closer together, GKPTN is actively strengthening the global kidney disease research community’s capacity to facilitate more rapid translation of new interventions from research into practice.
George Clinical: The Clinical Research Organization of Choice to Conduct Renal Trials
Facilitated by a kidney site network considered to be one of the strongest in the world, especially in the Asia-Pacific region, George Clinical owns an enviable position as a trusted partner in kidney and metabolic clinical research around the globe. Our scientific expertise collaborates with sponsors to develop new strategies for the prevention and management of renal and metabolic disease specifically including dialysis, chronic kidney disease (CKD), focal segmental glomerulosclerosis (FSGS), diabetic kidney disease, acute kidney injury and IgA nephropathy as well as the utility of genetics in drug development and discovery.
How does George Clinical set the standard in kidney and metabolic trials?
George Clinical leverages the in-depth expertise of our scientific leadership to design effective studies, select the best sites from more than 20 countries internationally and accelerate recruitment. Our scientific leaders generate strong evidence to implement real change in treatments, clinical practice and policy.
What are we doing to continually improve studies?
- Sponsors markedly benefit by collaborating with us from the earliest stages envisioning a trial to the final detailed meta-analysis and clinical conclusions
- Aligning with a veteran CRO partner such George Clinical versed in everything from protocol design, site analysis, project management and regulatory compliance reduces both the time to initiate and complete studies as well as the risk of disruption or study failure
- Continuing to advance clinical research methods in this space, George Clinical launched the Global Kidney Patients Trials Network to improve sponsor’s path to market while reducing overall study cost
- By bringing patients, established sites, sponsors and trials closer together, GKPTN strengthens the global kidney disease research community’s capacity to facilitate more rapid translation of new interventions from research into practice
What should a sponsor expect from working with us?
Working with George Clinical means studies activate quicker, recruit thoroughly, and meet or exceed budgetary expectations through the continuous support of dedicated, regionally savvy, cross-functional teams.
How do we efficiently help make renal trials a reality? We facilitate:
- Scientific leadership
- Advisory boards and designing protocols
- Selecting best possible clinical sites and reference requirements for various global environments
- Statistical analysis and data management
- Safety, quality and pharmacovigilance
- Regional regulatory interfaces and endpoint adjudication
Unparalleled Kidney Research Experience
George Clinical has earned a reputation as the leading kidney and metabolic CRO through a broad resume of landmark studies.
